Business
Covid-19:15 Second Home Testing GenViro! Swift Kit Identified By Largest CBS Affiliate In The Country As Potential Testing Solution To Help Get Country Back To Work
Covid-19:15 Second Home Testing GenViro! Swift Kit Identified By Largest CBS Affiliate In The Country As Potential Testing Solution To Help Get Country Back To Work.
About this update from Decision Diagnostics Corp
[{"type":"text","content":"WCBS-TV REPORT BY CHIEF HEALTH AND MEDICAL REPORTER DR. MAX GOMEZ, ALSO PICKED UP ON YAHOO NEWS, THEREBY REACHING A TOTAL AUDIENCE OF OVER 13 MILLION LOS ANGELES, CA / ACCESSWIRE / May 12, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc. the manufacturers and design specifiers for the GenViro! Covid-19 :15 test professional Swift Kit, today announced that it received detailed media coverage for its individual home testing version of the Swift Kit. Decision Diagnostics is an 18-year old, diabetes and now infectious disease testing bio-technology development firm, high-level manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for its own proprietary regulated medical devices. The story can be viewed in full at https://newyork.cbslocal.com/2020/05/05/coronavirus-covid-19-decision-diagnostics-testing/"Recognition from leading health and medical media is exactly what we want to more quickly build momentum toward testing that will be critical in helping the country get back to work," said CEO Keith Berman. "While we continue to wait for the FDA to APPROVE last issue in our testing protocol, even as we have begun the testing, it is important the public know through respected, independent third-parties in the media that true assistance in combatting the virus that has virtually paralyzed our country is being sought as quickly as possible TO answer the needs of individuals and businesses alike."Our GenViro! Covid-19 professional test kit is currently in the FDA EUA review process and we have received the Pre-EUA Acknowledgement letter from the U.S. FDA for device (serial number) PEUA200232, GenViro Covid-19 Screening Kit. We have since submitted a similar, but more complicated application for our individual home testing kit. This new kit has also received an FDA Acknowledgement letter, for device (serial number) PEUA200947. With receipt of the PEUA letters, the FDA discloses that review staff is assigned to the application. We are especially hopeful of obtaining regulatory approval that will allow Emergency Use for our at-home GenViro! product, which we believe to have the greatest market appeal.Health care officials and politicians recognize that large-scale...